Zoledronate and ion-releasing resins impair dentin collagen degradation

J Dent Res. 2014 Oct;93(10):999-1004. doi: 10.1177/0022034514546043. Epub 2014 Jul 29.

Abstract

This study analyzed the amounts of solubilized telopeptides cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and C-terminal crosslinked telopeptide of type I collagen (CTX) derived from matrix-metalloproteinases (MMPs) and cysteine cathepsins (CTPs) subsequent to application of a filler-free (Res.A) or an ion-releasing resin (Res.B) to ethylenediaminetetraacetic acid (EDTA)-demineralized dentin with or without zoledronate-containing primer (Zol-primer) pre-treatment. The chemical modification induced following treatments and artificial saliva (AS) storage was also analyzed through attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR). Totally EDTA-demineralized specimens were infiltrated with Res.A or Res.B with or without Zol-primer pre-treatment, light-cured, and immersed in AS for up to 4 wk. ICTP release was reduced following infiltration with Res.B and further reduced when Res.B was used with Zol-primer; remarkable phosphate mineral uptake was attained after AS storage. CTX release was increased in Res.A- and Res.B-treated dentin. However, when Zol-primer was used with Res.A, the CTX release fell significantly compared to the other tested resin-infiltration methods. In conclusion, zoledronate offers an additional inhibitory effect to the ion-releasing resins in MMP-mediated collagen degradation. However, Zol-primer induces a modest reduction in CTX release only when used with resin-based systems containing no ion-releasing fillers.

Keywords: bisphosphonates; calcium phosphates; cathepsins; matrix metalloproteinase; phosphorylation; proteolysis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aluminum Compounds / pharmacology
  • Bone Density Conservation Agents / pharmacology*
  • Calcium Compounds / pharmacology
  • Calcium Phosphates / pharmacology
  • Calcium Sulfate / pharmacology
  • Cathepsins / antagonists & inhibitors
  • Cathepsins / pharmacology
  • Collagen / drug effects*
  • Collagen Type I / analysis
  • Dentin / drug effects*
  • Diphosphonates / pharmacology*
  • Edetic Acid / pharmacology
  • Humans
  • Hydrogen-Ion Concentration
  • Imidazoles / pharmacology*
  • Materials Testing
  • Matrix Metalloproteinase Inhibitors / pharmacology
  • Matrix Metalloproteinases / pharmacology
  • Peptides / analysis
  • Resin Cements / pharmacology*
  • Saliva, Artificial / chemistry
  • Silicates / pharmacology
  • Solubility
  • Spectroscopy, Fourier Transform Infrared
  • Tooth Demineralization / chemically induced
  • Zoledronic Acid

Substances

  • Aluminum Compounds
  • Bone Density Conservation Agents
  • Calcium Compounds
  • Calcium Phosphates
  • Collagen Type I
  • Diphosphonates
  • Imidazoles
  • Matrix Metalloproteinase Inhibitors
  • Peptides
  • Resin Cements
  • Saliva, Artificial
  • Silicates
  • beta-tricalcium phosphate
  • collagen type I trimeric cross-linked peptide
  • dicalcium silicate
  • calcium aluminate
  • tricalcium silicate
  • Zoledronic Acid
  • Collagen
  • Edetic Acid
  • Cathepsins
  • Matrix Metalloproteinases
  • Calcium Sulfate